An Open-Label Extension Study of BPN14770 in Subjects With Fragile X Syndrome | ClinicalTrials HQ

Ask about research services

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
An Open-Label Extension Study of BPN14770 in Subjects With Fragile X Syndrome	Congenital Abnormalities, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Neurobehavioral Manifestations, Neurologic Manifestations, Sex Chromosome Disorders, X-linked disease, chromosomal disorder, fragile X syndrome, hereditary disease, inherited neurodegenerative disorder, intellectual disability, nervous system disorder	Active, not recruiting	Phase 3	2025-10-03		NCT05367960

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
Tetra Discovery Partners	1

17 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
Amnova Clinical Research	Irvine	United States	3
Boston Children's Hospital	Boston	United States	343
Children's Hospital Colorado	Aurora	United States	312
Cincinnati Children's Hospital Medical Center	Cincinnati	United States	405
Clinic for Special Children	Strasburg	United States	2
Emory University School of Medicine	Atlanta	United States	47
Greenwood Genetic Center	Greenville	United States	2
Icahn School of Medicine at Mount Sinai	New York	United States	342
Kennedy Krieger Institute	Baltimore	United States	41
MIND Institute UC Davis Medical Center	Sacramento	United States	1
Rush University Medical Center	Chicago	United States	283
Suburban Research Associates	Media	United States	9
Thompson Autism & Neurodevelopment Center - CHOC	Orange	United States	1
U Mass	Worcester	United States	1
University of Kansas Medical Center	Kansas City	United States	240
University of Miami	Miami	United States	327
University of Utah and Primary Children's Hospital	Salt Lake City	United States	1